CIDRZ: A Stronger Institution for Health and Development

Foreign Policy Association Blog by Dr Jim Quirk on 21 June 2016

CIDRZ Recovery: Stronger Institutions for Health and Development

HIV to Ebola to Zika, the effectiveness of public health responses has never been more critical, and organizations conducting this work are under increasing scrutiny. CIDRZ has addressed an issue shared by many developing-world health institutions: serious gaps in its organizational capacity to fulfill its mission. Read more here:

http://foreignpolicyblogs.com/2016/06/21/cidrz-institutions-health-development/

Call for Abstracts for 2016 Pharmacy Research Conference – Deadline 30 June 2016

CALL FOR ABSTRACTS
For the 
3rd Annual Pharmacy Research Conference 19th-20th July at the Taj Pamodzi Hotel, in Lusaka

THEME:  Reducing Disease Burden through Pharmaceutical Care and Research

The Ministry of Health in collaboration with CIDRZ and the WHO will host the 3rd Annual Pharmacy Research Conference in Lusaka. The conference will provide plenary sessions, panel discussions, oral and poster presentations, discussions on current pharmacy practice and an opportunity to share ideas for successful programmes and research studies that have worked in other healthcare systems.

Suitable Abstracts from Pharmacy Students (under and post-graduate), Pharmacy Technologists and Pharmacists are invited for oral and poster presentation relevant to the following topics:

  • Paediatric Care
  • Women’s Health
  • Operational Research
  • Pharmacovigilance
  • Clinical Pharmacy
  • Logistics and Supply Chain

Submission Deadline: 11:59 pm CAT June 30, 2016           

Guidelines:
*Note that presenting an abstract is voluntary. 

  • All abstracts should be in English.
  • Incomplete or inaccurate abstracts will be rejected
  • No more than 02 abstracts per attendee: one oral and one poster.
  • Capitalize the first word of the title only
  • Provide a concise statement (max. 500 words) of the Background, Research Aims/Objectives, Methodology, Results/Findings and Conclusions. The title and author’s names are not included in the word limit.
  • Use Arial, 10pt font, single-spaced and left aligned. DO NOT use all caps.
    Use standard abbreviations only. Within the body of the abstract, spell out the name in full at the first mention and follow with the abbreviation in parenthesis. Abbreviations may be used in the title, provided the name in full is outlined in the body of the abstract.

To Submit your Abstract:
Email your completed abstract and the required information below to both:

Mr Boyd Mwanashimbala        chipoboyd@yahoo.com          0977 877 070
Ms Helen Bwalya Mulenga      helen.mulenga@cidrz.org      0977 780 594

Please Include in your email:

  • Abstract Title
  • Topic – (max. 500 words) in the following format
    • Background
    • Research Aims/Objectives
    • Methodology
    • Results/Findings
    • Conclusions
  • Presenting Author, institutional affiliation, contact details, and email
  • Name and Organisation of Co-Authors in the order they should appear in the Abstract book
  • A brief biography (no more than 50 words) of the Presenting Author
    Indicate Oral or Poster preference

Abstract Evaluation Process and Criteria:
The Pharmacy Scientific Programme Committee will review abstracts beginning 1st July 2016. Abstracts not meeting the criteria below, as determined by the Pharmacy Scientific Programme Committee, will be rejected. The Committee will contact authors with formal acceptance or rejection notices as soon as possible. All notifications will be sent to the email address provided during the abstract submission process. The Committee will indicate the format of presentation: either oral or poster.

Abstracts will be evaluated based on the following criteria:

  • —Scientific merit
  • Direct relevance to the field of pharmacy
  • Submission of a clearly written, well organised abstract
  • Adherence to the submission guidelines outlined above

Dissemination of Abstracts:

Abstracts will be published in the 2016 Pharmacy Conference Book of Abstracts and disseminated to all conference attendees in electronic format.

Withdrawal of Submitted Abstract:

If you withdraw your Abstract submission, please email chipoboyd@yahoo.com AND helen.mulenga@cidrz.org

Thank you for your interest in presenting at the conference

Addendum 1 to Tender for Design/Supply/Installation of Solar Power at CIDRZ Lab: Closing Date now 22nd June 2016

ADDENDUM 1

Tender For The Design, Supply and Installation of Solar Power at CIDRZ Central Laboratory, Kalingalinga, Lusaka – CIDRZ/LABSOLAR/094/2016

CIDRZ wishes to inform all prospective bidders to this tender about the following amendments to the Bid Data Sheet:

Clause ITB 19.1: The closing date for the receipt of bids has been extended to Wednesday, 22nd June 2016 at 14:30 hours Central Africa Time. 

Clause ITB 25.3: The acceptable currency for this tender shall be any freely convertible currency.

Clause ITB 26.5 (b) (i): Delivery period acceptable is 12 weeks.

Clause ITB 27: All Domestic preference categories are applicable.

Clause ITB 27.2: For Joint Ventures where a local company has partnered with a foreign company is not mandatory but applicable.

NOTE: It is a requirement that ALL (Local and International) bidders should comply with terms and conditions regards licensing for Manufacture, Design and Installation of all solar equipment as regulated by the Energy Regulation Board (ERB). It is therefore the responsibility of prospective bidders to contact the ERB for any further clarifications regarding this matter.

Inonge Shabeenzu signature

INONGE SIMUSHI SHABEENZU

Head Procurement & Supplies